Treatment of systemic arterial hypertension: an integrative literature review about Hydrochlorothiazide vs Chlortalidone

Authors

DOI:

https://doi.org/10.33448/rsd-v11i11.33842

Keywords:

Chlorthalidone; Hydrochlorothiazide; Hypertension.

Abstract

Objective: To carry out an integrative literature review seeking to analyze the main differences in the use of Hydrochlorothiazide vs Chlorthalidone, in order to understand whether any drug overlaps the other. Methodology: This integrative literature review was carried out, analyzing articles from January 2010 to June 2022, in Portuguese, English and Spanish in the following databases: MEDLINE via PubMed, Europe PMC, Lilacs and SciELO. The descriptors used were “Chlorthalidone”, “Hydrochlorothiazide” and “Hypertension”, according to the DeCS, covering 31 articles at the end. Results: Several studies point to a more intense effect of chlorthalidone on hydrochlorothiazide, but emphasize that the former has greater adverse effects, such as hypokalemia and hyponatremia. Some studies show that the use of chlorthalidone over hydrochlorothiazide brought about a reduction in cardiovascular risk of approximately 18%, a result that has been much debated in the literature as it is the result of an indirect meta-analysis. Conclusion: The literature still differs regarding the use of chlorthalidone over hydrochlorothiazide, requiring further conclusive studies on the direct comparative effect between the two drugs. Literature data converge that chlorthalidone has a more intense effect than hydrochlorothiazide, bringing, however, more adverse effects to the patient, such as hyperkalemia, for example.

References

Bakris, G. L., Sica, D., White, W. B., Cushman, W. C., Weber, M. A., Handley, A., Song, E., & Kupfer, S. (2012). Antihypertensive efficacy of hydrochlorothiazide vs chlorthalidone combined with azilsartan medoxomil - PubMed. PubMed; pubmed.ncbi.nlm.nih.gov. https://pubmed.ncbi.nlm.nih.gov/22939358/

Barroso, W. K. S., Rodrigues, C. I. S., Bortolotto, L. A., Mota-Gomes, M. A., Brandão, A. A., Feitosa, A. D. D. M., ... & Nadruz, W. (2021). Diretrizes Brasileiras de Hipertensão Arterial–2020. Arquivos Brasileiros de Cardiologia, 116, 516-658. Doi: 10.36660/abc.20201238

Blowey, D. L. (2016). Diuretics in the treatment of hypertension - PubMed. PubMed; pubmed.ncbi.nlm.nih.gov. https://pubmed.ncbi.nlm.nih.gov/26983630/. Doi: 10.1007/s00467-016-3334-4.

Borelli, F.A.O. (2021). A hipopotassemia como efeito adverso dos diuréticos tiazídicos. Rev Bras Hipertens, 28(4), 288-92.

Cooney, D., Milfred-LaForest, S., & Rahman, M. (2015). Diuretics for hypertension: Hydrochlorothiazide or chlorthalidone? - PubMed. PubMed; pubmed.ncbi.nlm.nih.gov. https://pubmed.ncbi.nlm.nih.gov/26270432/. Doi: 10.3949/ccjm.82a.14091

de Souza, M. T., da Silva, M. D., & Carvalho, R. de. (2010). SciELO - Brasil - Integrative review: what is it? How to do it? Integrative review: what is it? How to do it? SciELO - Brasil - Integrative Review: What Is It? How to Do It? Integrative Review: What Is It? How to Do It?; www.scielo.br. https://www.scielo.br/j/eins/a/ZQTBkVJZqcWrTT34cXLjtBx/. Doi: 10.1590/S1679-45082010RW1134

Dhalla, I. A., Gomes, T., Yao, Z., Nagge, J., Persaud, N., Hellings, C., Mamdani, M. M., & Juurlink, D. N. (2013). Chlorthalidone versus hydrochlorothiazide for the treatment of hypertension in older adults: a population-based cohort study - PubMed. PubMed; pubmed.ncbi.nlm.nih.gov. https://pubmed.ncbi.nlm.nih.gov/23552325/. Doi: 10.7326/0003-4819-158-6-201303190-00004

Dineva, S., Uzunova, K., Pavlova, V., Filipova, E., Kalinov, K., & Vekov, T. (2020). Network meta-analysis of efficacy and safety of chlorthalidone and hydrochlorothiazide in hypertensive patients - PMC. PubMed Central (PMC); www.ncbi.nlm.nih.gov. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7932752/. Doi: 10.1097/MBP.0000000000000486

Dineva, S., Uzunova, K., Pavlova, V., Kalinov , K., & Vekov , T. (2019). Comparative efficacy and safety of chlorthalidone and hydrochlorothiazide-meta-analysis - PubMed. PubMed; pubmed.ncbi.nlm.nih.gov. https://pubmed.ncbi.nlm.nih.gov/31595024/. Doi: 10.1038/s41371-019-0255-2. Doi: 10.1038/s41371-019-0255-2

Dorsch, M. P., Gillespie, B. W., Erickson, S. R., Bleske, B. E., & Weder, A. B. (2011). Chlorthalidone reduces cardiovascular events compared with hydrochlorothiazide: a retrospective cohort analysis - PubMed. PubMed; pubmed.ncbi.nlm.nih.gov. https://pubmed.ncbi.nlm.nih.gov/21383313/. Doi: 10.1161/HYPERTENSIONAHA.110.161505

Filipova, E., Dineva, S., Uzunova, K., Pavlova, V., Kalinov, K., & Vekov, T. (2020). Combining angiotensin receptor blockers with chlorthalidone or hydrochlorothiazide – which is the better alternative? A meta-analysis - Systematic Reviews. BioMed Central; https://systematicreviewsjournal.biomedcentral.com/articles/10.1186/s13643-020-01457-9. Doi: 10.1186/s13643-020-01457-9

Flack, J. m, & Adekola, B. (2020). Blood pressure and the new ACC/AHA hypertension guidelines - PubMed. PubMed; pubmed.ncbi.nlm.nih.gov. https://pubmed.ncbi.nlm.nih.gov/31521481/. Doi: 10.1016/j.tcm.2019.05.003

Fuchs, Flavio Dannis. (2016). Comparação Entre Medicamentos Para Tratamento Inicial Da Hipertensão Arterial Sistêmica. Uso Racional de Medicamentos: fundamentação em condutas terapêuticas e nos macroprocessos da Assistência Farmacêutica.

Hripcsak, G., Suchard, M. A., Shea, S., Chen, R., You, S. C., Pratt, N., ... & Schuemie, M. J. (2020). Comparison of cardiovascular and safety outcomes of chlorthalidone vs hydrochlorothiazide to treat hypertension. JAMA internal medicine, 180(4), 542-551. https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2760777. Doi: 10.1001/jamainternmed.2019.7454

Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P., ... & Moher, D. (2009). The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Journal of clinical epidemiology, 62(10), e1-e34. https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1000100. Doi: 10.1371/journal.pmed.1000100

Longo, M. A. T., Martelli, A., & Zimmermann, A. (2011). Hipertensão arterial sistêmica: aspectos clínicos e análise farmacológica no tratamento dos pacientes de um setor de psicogeriatria do Instituto Bairral de Psiquiatria, no município de Itapira, SP. Revista Brasileira de Geriatria e Gerontologia, 14, 271-284. Doi: 10.1590/S1809-98232011000200008

MAHBOOB RAHMAN, M. D. (2015). Diuretics for hypertension: Hydrochlorothiazide or chlorthalidone. Cleveland Clinic journal of medicine, 82(8), 527.

Meyer, J. C. L. (2013). Comparación entre la eficacia y los riesgos de la hidroclorotiazida y la clortalidona en la prevención primaria de eventos vasculares. Evidencia, actualizacion en la práctica ambulatoria, 16(3). https://www.evidencia.org/index.php/Evidencia/article/view/6178. Doi: 10.51987/evidenciav16i3.6178

Muela, H. C., Costa‐Hong, V. A., Yassuda, M. S., Moraes, N. C., Memória, C. M., Machado, M. F., ... & Bortolotto, L. A. (2017). Hypertension severity is associated with impaired cognitive performance. Journal of the American Heart Association, 6(1), e004579. Doi: 10.25060/residpediatr

Pareek, A. K., Messerli, F. H., Chandurkar, N. B., Dharmadhikari, S. K., Godbole, A. V., Kshirsagar, P. P., ... & Kumbla, M. M. (2016). Efficacy of low-dose chlorthalidone and hydrochlorothiazide as assessed by 24-h ambulatory blood pressure monitoring. Journal of the American College of Cardiology, 67(4), 379-389. https://pubmed.ncbi.nlm.nih.gov/26821625/. Doi: 10.1016/j.jacc.2015.10.083

Póvoa, F. F., & Póvoa, R. (2020). Existem diferenças entre os diuréticos tiazídicos? Rev Bras Hipertens, 27(3), 103-5. https://pesquisa.bvsalud.org/portal/resource/pt/biblio-1368070. Doi: 10.47870/1519-7522/20202703103-105

Psaty, B. M., Lumley, T., & Furberg, C. D. (2004). Meta-analysis of health outcomes of chlorthalidone-based vs nonchlorthalidone-based low-dose diuretic therapies. JaMa, 292(1), 43-43. Doi: doi:10.1001/jama.292.1.43-c

Roush, G. C., Holford, T. R., & Guddati, A. K. (2012). Chlorthalidone compared with hydrochlorothiazide in reducing cardiovascular events: systematic review and network meta-analyses. Hypertension, 59(6), 1110-1117. Doi: 10.1161/HYPERTENSIONAHA.112.191106

Saseen, J. J., Ghushchyan, V., & Nair, K. V. (2015). Comparing clinical effectiveness and drug toxicity with hydrochlorothiazide and chlorthalidone using two potency ratios in a managed care population. The Journal of Clinical Hypertension, 17(2), 134-140. Doi: 10.1111/jch.12453

Santos, M. A. R. C., & Galvão, M. G. A. (2014). A elaboração da pergunta adequada de pesquisa. Resid Pediatr, 4(2), 53-56. Doi: 10.25060/residpediatr

Sato, K., Dohi, Y., Kojima, M., Takase, H., Suzuki, S., & Ito, S. (2010). Antioxidative effects of thiazide diuretics in refractory hypertensive patients. A randomized crossover trial of chlortalidone and trichlormethiazide. Arzneimittel-forschung, 60(10), 612-616. Doi: 10.1055/s-0031-1296334

Sousa, C. T., Ribeiro, A., Barreto, S. M., Giatti, L., Brant, L., Lotufo, P., ... & Figueiredo, R. C. (2022). Diferenças Raciais no Controle da Pressão Arterial em Usuários de Anti-Hipertensivos em Monoterapia: Resultados do Estudo ELSA-Brasil. Arquivos Brasileiros de Cardiologia, 118, 614-622. Doi: 10.36660/abc.20201180

Springer, K. (2015). Chlorthalidone vs. hydrochlorothiazide for treatment of hypertension. American Family Physician, 92(11), 1015.

van Blijderveen, J. C., Straus, S. M., Rodenburg, E. M., Zietse, R., Stricker, B. H., Sturkenboom, M. C., & Verhamme, K. M. (2014). Risk of hyponatremia with diuretics: chlorthalidone versus hydrochlorothiazide. The American journal of medicine, 127(8), 763-771. Doi: 10.1016/j.amjmed.2014.04.014

Vongpatanasin, W. (2015). Hydrochlorothiazide (HCTZ) is not the most useful nor versatile thiazide diuretic. Current opinion in cardiology, 30(4), 361. Doi: 10.1097/HCO.0000000000000178

Woodman, R., Brown, C., & Lockette, W. (2010). Chlorthalidone decreases platelet aggregation and vascular permeability and promotes angiogenesis. Hypertension, 56(3), 463-470. Doi: 10.1161/HYPERTENSIONAHA.110.154476

Downloads

Published

23/08/2022

How to Cite

NASCIMENTO, Y. S. .; NASCIMENTO, Y. S. .; FERREIRA, L. M. R. .; CUNHA NETO, C. P.; SANTOS, C. R. A. C. dos .; MENEZES, A. S. .; SANTOS JUNIOR, R. F. dos . Treatment of systemic arterial hypertension: an integrative literature review about Hydrochlorothiazide vs Chlortalidone. Research, Society and Development, [S. l.], v. 11, n. 11, p. e288111133482, 2022. DOI: 10.33448/rsd-v11i11.33842. Disponível em: https://rsdjournal.org/index.php/rsd/article/view/33842. Acesso em: 19 apr. 2024.

Issue

Vol. 11 No. 11

Section

Health Sciences

License

Copyright (c) 2022 Yan Santiago Nascimento; Yago Santiago Nascimento; Letícia Maria Rendall Ferreira; Cícero Pereira Cunha Neto; Caio Roberto Alexandre Cavalcante dos Santos; Arthur Souza Menezes; Ricardo Ferreira dos Santos Junior

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.